Asset Quality Turnaround Masks Capex Timing Risk
ESAF delivered record PAT (+238% YoY), but ₹626 Cr in one-time NPA write-offs turbo-charged the number. The real story — cost-to-income collapsed 24 points and asset quality halved — is bullish, yet StratoNeXt capex and insurance headwinds temper the outlook.
₹160 Cr
+238% YoY
NPA write-off normalizes Q1 provisions
Cost-to-income 58%
–24 pts YoY
ESAF's reported profit jumped 238% year-on-year, a headline that screams blowout. Dig into the call, and the real story emerges: ₹626 crore in NPA write-offs released provisions that flowed through the P&L, turbo-charging reported PAT. Strip that out, and the underlying business—lower costs, vastly improved asset quality, profitable growth—is genuinely strong. But the near-term picture is crowded with near-equally-weighted risks: gold loan SMAs dependent on price recovery, StratoNeXt capex now ramping, and insurance income halved due to regulatory headwind. This quarter closes an era of pure microfinance and opens one of scaled, diversified lending—if management can thread the capex needle.
The one-time boost and where it sits
Reported PAT reached ₹160 crore in Q2, up from ₹80 crore in Q1. Management noted that the full quarter benefited from the release of provisions tied to the ₹626 crore in NPA write-offs taken in the quarter—a normalization that cleared the asset quality backlog and allowed the true operating PAT to surface. Without quantifying the exact P&L impact in the call, the magnitude suggests the bulk of the QoQ doubling was one-time. That said, the underlying margin structure—NII +73% YoY despite only 25% asset growth, cost-to-income collapsing 24 points to 58%—shows genuine operating leverage being unleashed.
Claims on the call vs. what holds up
Asset growth 27% YoY beats prior 22–25% guidance
Total business ₹52.4k Cr (25% YoY); net asset growth tracking 27% per stated progress
Supported
Gross NPA down to 2.8%, net NPA to 0.3%
Gross NPA 2.8% (down from 8.5% prior year); net NPA 0.3% (down from 3.8%); ₹626 Cr write-off cleared backlog
Supported
Cost-to-income improved to 58%, major efficiency gain
Cost-to-income 58% Q2 FY27 vs 82% Q2 FY26; verified via 2% QoQ OPEX growth on 7% revenue growth
Supported
Portfolio diversification—MARG 38% YoY, EH 134% YoY
MARG ₹13.9k Cr (38% YoY, 58% of portfolio); EH ₹14.5k Cr (134% YoY, 32% of advances); both asset quality good
Supported
NIM maintained above 7.5% target; Q2 at 8.2%
NIM 8.2% Q2 (stable vs rate hikes); cost of funds unchanged; deposit repricing capacity evident
Supported
ROA on track for 2% by FY27 exit
Annualized ROA 1.5% (80% of full-year target); guidance pulled forward from prior FY28 exit target
Supported (confidence high)
What changed on this call
Asset growth raised: 22–25% → 27% YoY
ROA target pulled forward: FY28 exit → FY27 exit
Insurance income halved (IRDA draft rules)—new headwind
Cost-to-income guidance 60% FY27 (vs current 58%)
Loan growth moderation: 3% QoQ signals portfolio shift, not demand weakness
The bull-bear ledger
Asset quality turnaround (NPA 8.5% → 2.8%) is structural, not one-time
Cost-to-income 58% shows operating leverage from scale; 60% guidance achievable
MARG/EH diversification into secured lending de-risks business model
StratoNeXt platform (live 26-Oct) unlocks branch automation and faster onboarding
Reported PAT leans 50%+ on one-time NPA provision release
Insurance income halved; regulatory headwind uncertain until IRDA final ruling
Gold SMA ₹1.3 Cr recovery dependent on price stabilization; 76% LTV conservative but limited upside
Loan growth 3% QoQ suggests macro headwinds or mix shift absorption—not sustainably high
Risks, ranked by holder concern
Gold SMA recovery dependency
Medium₹1.3 Cr in SMA-0/SMA-1 gold loans tied to price stabilization. 76% LTV conservative, but price continuation drop could extend recovery timeline. If gold prices remain weak, MARG (58% of portfolio) profitability takes a hit.
StratoNeXt capex absorption and cost-to-income guidance
MediumPlatform live 26-Oct; capex now accelerating. Management targets 60% cost-to-income FY27 vs current 58%, implying cushion. If quarterly OPEX growth exceeds 5%, guidance slip is possible—and credibility takes a hit.
Insurance income regulatory headwind
MediumInsurance halved YoY (₹25 Cr Q2 vs ₹124 Cr full FY26) due to IRDA draft rules pending finalization. If drastic restrictions materialize, offsetting arrangements uncertain—near-term P&L headwind of ₹50–100 Cr possible.
Loan growth moderation
LowLoan book growth 3% QoQ vs 7% revenue growth. Mix shift (MARG/EH higher-yield) explains NII divergence, but raw volume weakness could signal macro saturation or portfolio credit risk if it persists into H2.
Geographic concentration—drought and macro shock
LowMaharashtra + Karnataka = 15–16% of portfolio. Drought announced for Maharashtra; collection efficiency 99% to date, but prolonged drought could impact rural microloan repayment. Spread across 26 states mitigates but doesn't eliminate.
How the street is positioned
ESAF trades at ₹40.8 (as of 2026-11-03), below its 20-day (SMA at ₹41.94) and 50-day (₹41.86) averages but above the 200-day (₹32.74). The stock is down 50.4% from its all-time high but up 106.69% off its 52-week low, a V-shaped recovery that held post-result. RSI at 47.2 is neutral—no overbought condition. Volume is increasing, suggesting renewed interest. In flows, FII ownership ticked up to 0.32% (from 0.01% a quarter ago, +0.31pp), a small but directional inflow from foreign institutions. DII trimmed 0.83pp to 3.80%, while promoters held firm at 63.25%. The FII uptick post-result suggests institutional validation of the asset quality narrative, but the small absolute ownership (0.32%) reflects the stock's limited foreign investor base. The net takeaway: the market is cautiously constructive post-result (price above key averages, volume lifting), but risk-off sentiment lingers—the stock hasn't broken its 52-week high and remains at a 50% discount from ATH.
The debate
What to watch next
1 · Gold price and SMA recovery
Gold SMA-0/SMA-1 buckets (₹1.3 Cr total) are the single biggest near-term pressure on MARG profitability. Q3 and Q4 will show whether ₹1k-plus per gram stabilization allows the portfolio to exit SMA status. If prices don't recover, MARG slippage could accelerate.
2 · StratoNeXt capex run-rate and cost-to-income guidance realization
Q3 FY27 will show actual capex spend post-26-Oct go-live. If quarterly OPEX growth stays 3–5% (absorbing capex) while revenue grows 8–10%, the 60% cost-to-income target is achievable. If OPEX grows 8%+, guidance slip is possible.
3 · Insurance final IRDA ruling and offsetting measures
IRDA's final guidance on insurance profitability caps is pending. Management is pre-building offsetting arrangements; Q3–Q4 earnings calls will reveal whether the offset is real or aspirational. A ₹30–50 Cr annual headwind is realistic; anything more is a surprise negative.
The number to track from here
Cost-to-income guidance of 60% for FY27 is the single most important number. It encodes all three risks (StratoNeXt capex, insurance headwind, loan growth moderation) into one metric. If ESAF delivers 58–60% cost-to-income for full FY27 despite capex, insurance drag, and macro headwinds, the thesis holds and capex is a temporary pain for long-term gain. If cost-to-income slips to 62%+, the guidance credibility fractures—and near-term re-rating will be limited.
ESAF Small Finance Bank's Q2 is a quarter of genuine operational achievement (NPA halved, cost-to-income down 24 points, ROA on track) shadowed by equally genuine near-term headwinds (gold SMA, capex, insurance). The reported profit of ₹160 crore is not a clean read—₹626 crore in one-time write-offs inflated the number—but the underlying momentum is intact. This is a steady-execution story with a capex timing risk in the next 6 months. The stock's 50% drawdown from ATH and neutral technicals offer a fair entry for holders who believe management can thread the needle; sellers are not wrong either, given the headline risks and macro uncertainty. Watch cost-to-income guidance realization in Q3–Q4 FY27 as the arbiter.
Informational and educational content only. Not investment advice.